Time-Sensitive Research to Assess the Effects of Reproductive Health Policy on the Health Outcomes of People with Chronic Diseases
评估生殖健康政策对慢性病患者健康结果影响的时间敏感研究
基本信息
- 批准号:10768227
- 负责人:
- 金额:$ 68.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdvertisingAffectAgeBirthCardiovascular DiseasesCaringChronicChronic DiseaseClinicalComplexContraceptive methodsDangerousnessDataDecision MakingDisabled PersonsDiscipline of obstetricsDiseaseDrug PrescriptionsEligibility DeterminationEpidemiologyEquityFamily PlanningFemaleHealthHealth PolicyHealth ServicesHealthcareIndividualInterviewLegalLifeLow incomeMalignant NeoplasmsMaternal MortalityMedicaidMedicalMedicineOutcomeOutcome AssessmentPatient Outcomes AssessmentsPatientsPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacy facilityPhysiciansPoliciesPopulationPregnancyPregnancy OutcomePrimary CareProceduresPublic HealthRecommendationRecording of previous eventsRegulationReportingReproductive HealthResearchRespondentRiskSamplingSurveysSystemic Lupus ErythematosusTeratogensTimeTravelWomen&aposs Healthabortionadverse pregnancy outcomechild bearingclinical centerclinical practicecourtexperiencefetalhealth equityhealth practicehealthy pregnancyhigh riskindexingmultidisciplinaryperson centeredpopulation basedpregnantrecruitsearch enginesevere maternal morbiditysocialsocioeconomicsunintended pregnancy
项目摘要
ABSTRACT
In June 2022, the U.S. Supreme Court’s ruling in Dobbs v. Jackson Women’s Health overturned Roe v. Wade,
eliminating federal protections for abortion access nationwide. The Dobbs decision rapidly upended fifty years
of legal precedent and health policy. Fourteen states have banned abortion, state legislatures have introduced
85 bills to protect or restrict abortion access, and courts in eight states have temporarily blocked the passage of
abortion bans. Over 33.6 million people with childbearing capacity now live in states where abortion is banned
or likely to be heavily restricted. The effect of these rapidly changing policies on abortion access will be
profound, yet the consequences of these policies on public health indices are unknown. People with chronic
and complex medical conditions are particularly vulnerable to adverse health consequences as a result of
abortion policy. At baseline, these individuals are at high risk for severe maternal morbidity and maternal
mortality as compared to other birthing people. Prior to the Dobbs decision, abortion care allowed for life-
altering care among people whose underlying health conditions complicated healthy pregnancy. However, few
studies had described the impact of abortion on the health and well-being of individuals with chronic diseases;
thus, it is unclear how the Dobbs decision will impact their clinical outcomes. Our study, Investigating Time-
sensitive Reproductive Health Equity Post-Dobbs for Patients with ChronIc Disease (INTREPID), will evaluate
the time-sensitive impact of evolving abortion policies on the health and well-being of patients, particularly
those with chronic diseases that increase the risk of severe maternal morbidity and maternal mortality (e.g.,
cardiovascular disease, cancer, systemic lupus erythematosus); the clinical practice of physicians who care for
people with chronic diseases; and downstream clinical outcomes at a population level. We will use survey-
based, qualitative, and epidemiologic approaches to realize our Specific Aims, which are to: 1) Evaluate,
among people who are seeking abortion, who is able or not able to obtain a wanted abortion, and to assess their
longitudinal outcomes related to health and well-being; 2) Assess, among physicians, the impact of abortion
policy on medical decision-making and practice; and 3) Generate new evidence about the impact of abortion
policy on population-based pregnancy outcomes (e.g., severe maternal morbidity, maternal mortality) and
healthcare-related outcomes (e.g., contraception and teratogenic medication prescribing). The INTREPID
research team has multidisciplinary expertise in medicine, obstetrics, family planning research, health equity,
health policy, and epidemiology. Our project seeks to inform health policy that will optimize reproductive
healthcare and clinical outcomes in the post-Dobbs era.
抽象的
2022年6月,美国最高法院对多布斯诉杰克逊妇女健康案的裁决推翻了罗伊诉韦德案,
取消对全国范围内堕胎的联邦保护。多布斯的决定迅速颠覆了五十年的历史。
州立法机构已经制定了法律先例和卫生政策的规定,已有 14 个州禁止堕胎。
85 项保护或限制堕胎的法案,八个州的法院暂时阻止了该法案的通过
目前有超过 3360 万有生育能力的人生活在禁止堕胎的州。
这些快速变化的政策对堕胎的影响可能会受到严格限制。
但这些政策对慢性病患者的公共卫生指数的影响尚不清楚。
复杂的医疗状况特别容易因以下原因而对健康造成不良后果:
在基线时,这些人面临严重孕产妇发病和孕产妇死亡的高风险。
在多布斯做出决定之前,堕胎护理允许终生死亡。
改变对那些因潜在健康状况而导致健康怀孕变得困难的人的护理。
研究描述了堕胎对慢性病患者的健康和福祉的影响;
因此,尚不清楚多布斯的决定将如何影响他们的临床结果。
慢性病患者的敏感生殖健康公平后多布斯 (INTREPID) 将评估
不断发展的堕胎政策对患者健康和福祉的时间敏感影响,特别是
患有会增加严重孕产妇发病和孕产妇死亡风险的慢性疾病的人(例如,
心血管疾病、癌症、系统性红斑狼疮);
患有慢性疾病的人;以及人口层面的下游临床结果。
基于定性和流行病学的方法来实现我们的具体目标,这些目标是:1)评估,
在寻求堕胎的人中,谁能够或不能获得想要的堕胎,并评估他们的情况
与健康和福祉相关的纵向结果;2) 在医生中评估堕胎的影响
医疗决策和实践的政策;以及 3) 产生有关堕胎影响的新证据
基于人口的妊娠结局政策(例如严重孕产妇发病率、孕产妇死亡率)以及
医疗保健相关结果(例如,避孕和致畸药物处方)。
研究团队拥有医学、产科、计划生育研究、健康公平、
我们的项目旨在为优化生殖健康的卫生政策提供信息。
后多布斯时代的医疗保健和临床结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mehret Birru Talabi其他文献
Development of ReproKnow, a reproductive knowledge assessment for women with rheumatic diseases
开发 ReproKnow,针对患有风湿病的女性进行生殖知识评估
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:2.2
- 作者:
Mehret Birru Talabi;M. Clowse;S. Blalock;G. Switzer;Lanskikh Yu;Alaina Chodoff;S. Borrero - 通讯作者:
S. Borrero
A Case of Unremitting Fevers
高烧不退一例
- DOI:
10.1002/acr.23800 - 发表时间:
2019 - 期刊:
- 影响因子:4.7
- 作者:
Kanchana Herath;L. Contis;N. Aggarwal;Mehret Birru Talabi - 通讯作者:
Mehret Birru Talabi
Overturning Roe v. Wade: Toppling the Practice of Rheumatology
推翻罗伊诉韦德案:推翻风湿病学实践
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:13.3
- 作者:
B. Bermas;I. Blanco;Ashira Blazer;M. Clowse;C. Edens;R. Ramsey‐Goldman;Mehret Birru Talabi - 通讯作者:
Mehret Birru Talabi
A Framework for Femtech: Guiding Principles for Developing Digital Reproductive Health Tools in the United States
女性科技框架:美国开发数字生殖健康工具的指导原则
- DOI:
10.2196/preprints.36338 - 发表时间:
2022 - 期刊:
- 影响因子:7.4
- 作者:
T. Krishnamurti;Mehret Birru Talabi;L. Callegari;T. Kazmerski;S. Borrero - 通讯作者:
S. Borrero
Antirheumatic medications in pregnancy and breastfeeding.
妊娠期和哺乳期的抗风湿药物。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:5.1
- 作者:
Mehret Birru Talabi;M. Clowse - 通讯作者:
M. Clowse
Mehret Birru Talabi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mehret Birru Talabi', 18)}}的其他基金
Development of a novel, patient-centered measure of reproductive autonomy in the healthcare context
在医疗保健环境中开发一种新颖的、以患者为中心的生殖自主权测量方法
- 批准号:
10508732 - 财政年份:2022
- 资助金额:
$ 68.17万 - 项目类别:
Development of a novel, patient-centered measure of reproductive autonomy in the healthcare context
在医疗保健环境中开发一种新颖的、以患者为中心的生殖自主权测量方法
- 批准号:
10670966 - 财政年份:2022
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10683187 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10263313 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10478252 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
Investigating Pathways to Optimal Reproductive Outcomes Among Women with Rheumatic Diseases
研究患有风湿病的女性获得最佳生殖结果的途径
- 批准号:
10054710 - 财政年份:2020
- 资助金额:
$ 68.17万 - 项目类别:
相似国自然基金
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
年龄结构和空间分布对艾滋病的影响:建模、分析与控制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
随机噪声影响下具有年龄结构的布鲁氏菌病动力学行为与最优控制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
AppalTRuST Project 2: Exposure to tobacco marketing for novel tobacco products and associations with future tobacco use in Appalachian young adults: tobacco regulatory science implications
AppalTrust 项目 2:接触新型烟草产品的烟草营销以及与阿巴拉契亚年轻人未来烟草使用的关联:烟草监管科学影响
- 批准号:
10665321 - 财政年份:2023
- 资助金额:
$ 68.17万 - 项目类别:
Appalachian Tobacco Regulatory Science Team (AppalTRuST)
阿巴拉契亚烟草监管科学团队 (AppalTRuST)
- 批准号:
10665319 - 财政年份:2023
- 资助金额:
$ 68.17万 - 项目类别:
Modeling the equity impact of age restricted in-person location policies for youth tobacco use
模拟年龄限制的现场政策对青少年烟草使用的公平影响
- 批准号:
10660348 - 财政年份:2023
- 资助金额:
$ 68.17万 - 项目类别:
Digital Delivery of Evidence-Based Mental Health Content and Mentoring to Adolescents
以数字方式向青少年提供循证心理健康内容和指导
- 批准号:
10758731 - 财政年份:2023
- 资助金额:
$ 68.17万 - 项目类别:
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
MyPEEPS Mobile LITE:MyPEEPS Mobile 的有限交互功效试验可降低 YMSM 中的 HIV 发病率并更好地了解 HIV 流行病学
- 批准号:
10462265 - 财政年份:2022
- 资助金额:
$ 68.17万 - 项目类别: